Axonics Modulation Technologies, Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Axonics Modulation Technologies, Inc.
The France-based firm has assembled a strong syndicate for its sixth generation of 'BioDiscovery' funds, consolidating its position as one of the leading players in life sciences venture capital in Europe.
The US patent office has upheld all seven patents at issue, with the verdict on the final three having come on 22 September.
Medtronic’s revenue of $6.5bn in the first quarter of fiscal 2021 represents a 17% fall year-over-year, but it still beat analysts’ projections.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
- Contura Limited
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.